Le Lézard
Classified in: Health
Subject: SVY

General and Pelvic Endoscopic Surgery Devices Markets, 2019 - Focus on US, France, Germany, Italy, Spain, the UK, Japan & RoW


DUBLIN, Aug. 23, 2019 /PRNewswire/ -- The "General and Pelvic Endoscopic Surgery Devices" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report provides an in-depth analysis of the global market for medical devices used in endoscopic general and pelvic surgeries.

Endoscopic medical devices covered in this market analysis include:

Markets covered include the US, the five major EU markets (France, Germany, Italy, Spain, the UK), Japan, and the rest of the world.

This report provides the following useful information:

Key Questions Answered:

Highlights:

  1. Approximately 25 million general and pelvic endoscopy procedures were performed worldwide in 2018; these included general endoscopy, OB/GYN, and urologic endoscopy procedures.
  2. The global market for general and pelvic endoscopic surgery products totaled approximately $13bn in 2018, and is expected to climb at a CAGR of 6.4% over the forecast period covered by this analysis.
  3. Within the combined market, hand instruments accounted for approximately 53% of sales in 2018.
  4. Leading competitors in the market for general and pelvic endoscopic surgery products include Ethicon/Johnson & Johnson, Medtronic, and Olympus, among others

Key Topics Covered:

Executive Summary
i. Global market
ii. Methodology

1. General and Pelvic Endoscopic Surgery Procedures

1.1 General endoscopic surgical procedures
1.2 Obstetric/gynecologic surgical procedures
1.3 Urologic surgery procedures
1.4 Bibliography

2. General and Pelvic Endoscopic Surgery Products

2.1 Access devices
2.1.1 Types of access devices
2.1.2 Products
2.2 Insufflation products
2.2.1 Products
2.3 Endoscopes
2.3.1 Types of endoscopes
2.3.2 Products
2.4 Endoscopic hand instruments
2.4.1 Products
2.5 Ancillary endoscopic surgery devices
2.5.1 Products
2.6 Endoscopic access site closure devices
2.6.1 Types of endoscopic access site closure products
2.6.2 Products
2.7 Bibliography

3. Endoscopy Access Devices Market
3.1 Market forecast: worldwide
3.1.1 Competitive analysis: worldwide
3.2 Market forecast: US
3.2.1 Competitive analysis: US
3.3 Market forecast: five major EU markets
3.3.1 Competitive analysis: five major EU markets
3.4 Market forecast: Japan
3.4.1 Competitive analysis: Japan
3.5 Market forecast: rest of the world
3.5.1 Competitive analysis: rest of the world
3.6 Bibliography

4. Insufflation Products Market

4.1 Market forecast: worldwide
4.1.1 Competitive analysis: worldwide
4.2 Market forecast: US
4.2.1 Competitive analysis: US
4.3 Market forecast: five major EU markets
4.3.1 Competitive analysis: five major EU markets
4.4 Market forecast: Japan
4.4.1 Competitive analysis: Japan
4.5 Market forecast: rest of the world
4.5.1 Competitive analysis: rest of the world
4.6 Bibliography

5. Endoscopes Market

5.1 Market forecast: worldwide
5.1.1 Competitive analysis: worldwide
5.2 Market forecast: US
5.2.1 Competitive analysis: US
5.3 Market forecast: five major EU markets
5.3.1 Competitive analysis: five major EU markets
5.4 Market forecast: Japan
5.4.1 Competitive analysis: Japan
5.5 Market forecast: rest of the world
5.5.1 Competitive analysis: rest of the world
5.6 Bibliography

6. Endoscopic Hand Instruments Market

6.1 Market forecast: worldwide
6.1.1 Competitive analysis: worldwide
6.2 Market forecast: US
6.2.1 Competitive analysis: US
6.3 Market forecast: five major EU markets
6.3.1 Competitive analysis: five major EU markets
6.4 Market forecast: Japan
6.4.1 Competitive analysis: Japan
6.5 Market forecast: rest of the world
6.5.1 Competitive analysis: rest of the world
6.6 Bibliography

7. Ancillary Endoscopic Devices Market

7.1 Market forecast: worldwide
7.1.1 Competitive analysis: worldwide
7.2 Market forecast: US
7.2.1 Competitive analysis: US
7.3 Market forecast: five major EU markets
7.3.1 Competitive analysis: five major EU markets
7.4 Market forecast: Japan
7.4.1 Competitive analysis: Japan
7.5 Market forecast: rest of the world
7.5.1 Competitive analysis: rest of the world
7.6 Bibliography

8. Endoscopic Access Site Closure Devices Market

8.1 Market forecast: worldwide
8.1.1 Competitive analysis: worldwide
8.2 Market forecast: US
8.2.1 Competitive analysis: US
8.3 Market forecast: five major EU markets
8.3.1 Competitive analysis: five major EU markets
8.4 Market forecast: Japan
8.4.1 Competitive analysis: Japan
8.5 Market Forecast: rest of the world
8.5.1 Competitive analysis: rest of the world
8.6 Bibliography

For more information about this report visit https://www.researchandmarkets.com/r/1lae8b

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 05:45
Exact Sciences Corp. announced today that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, Cologuard, for eligible average-risk individuals ages 45 and older, expanding on its previous indication...

at 05:40
CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry globally. As the initiator of an Internet platform for knowledge sharing in the pharmaceutical field, CPhI.CN aims to create hot industry content to achieve effective...

at 05:15
The "Navigating through the Maze of In-vitro Diagnostics (IVD) Regulations: A Systematic Approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada" conference has been added to ResearchAndMarkets.com's offering. This 2 day...

at 05:05
September 23, 2019 New report shows how to address the challenges of implementing digital health technology ? a catalyst for achieving Universal Health Coverage (UHC)Philips Chief Medical Officer Jan Kimpen discusses the creation of enabling...

at 05:05
The global healthcare interoperability solutions market size is expected to reach USD 4.7 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 13.0% during the forecast period. Rising focus on patient-centric...

at 04:05
Clovis Oncology, Inc. has entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications...



News published on 23 august 2019 at 10:45 and distributed by: